Biggest News Aggregation in the World
📰 Phase News

Page 1474 - Phase News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Phase. Real-time updates on events, politics, business and more.

Merck Advances ATR Inhibitor Berzosertib in Small Cell Lung Cancer With New Published Data and Initiation of Phase II Trial With Registrational Intent

Merck Advances ATR Inhibitor Berzosertib in Small Cell Lung Cancer With New Published Data and Initiation of Phase II Trial With Registrational Intent 1 A new company-sponsored, global clinical trial will further assess berzosertib in small cell lung cancer Merck is leading more than ten clinical trials across DNA Damage Response (DDR) pathways in various tumor types Merck, a leading science and technology company, today announced key clinical advancements for berzosertib (M6620), an investig...
United States Danish Thomas Julissa Viana National Cancer Institute Lasker Clinical Research Scholar Cancer Research

F. Hoffmann-La Roche Ltd: Phase III prevention trial showed subcutaneous administration of investigational antibody cocktail casirivimab and imdevimab reduced risk of symptomatic COVID-19 infections by 81%

F. Hoffmann-La Roche Ltd: Phase III prevention trial showed subcutaneous administration of investigational antibody cocktail casirivimab and imdevimab reduced risk of symptomatic COVID-19 infections by 81% Placebo Risk reduction 13 1.2 4 copies/mL) 14 0.4 * Individuals without any COVID-19 symptoms who lived in the same household as an individual who tested positive to SARS-CoV-2 within the prior four days . Based on the seronegative modified Full Analysis Set population, which includes al...
United Kingdom United States Nathalie Meetz Levi Garraway Daniel Grotzky Jon Kaspar Bayard

Applied DNA Sciences, Inc. and Takis Biotech/Evvivax: Applied DNA and Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial for LinearDNA COVID-19 Vaccine Candidate in Felines

Applied DNA Sciences, Inc. and Takis Biotech/Evvivax: Applied DNA and Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial for LinearDNA COVID-19 Vaccine Candidate in Felines - Strong Neutralizing Antibody Titer Elicited Across Cohort - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and its program development partner, Evvivax, S.R.L. ("Evvivax"), today announced positive preli...
United Kingdom Joseph Impellizeri Jamesa Hayward Antonella Conforti Luigi Aurisicchio Us Department Of Agriculture

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Immunocore Holdings Limited: Immunocore presents phase 3 data comparing tebentafusp with investigator's choice in the clinical trial plenary session at the American Association for Cancer Research 2021 Annual Meeting

(2) PRESS RELEASE Immunocore presents phase 3 data comparing tebentafusp with investigators choice in the clinical trial plenary session at the American Association for Cancer Research 2021 Annual Meeting Tebentafusp is the first investigational therapy to improve Overall Survival (OS) in patients with metastatic uveal melanoma First positive Phase 3 clinical trial for any T cell receptor therapeutic and first for any bispecific in a solid tumor (Nasdaq: IMCR), a late-stage biotechnology com...
Baden Wuberg United States Marcuso Butler Jessicac Hassel Immunocore Imm Debra Nielsen

21st Austria weekly - Valneva, S&T, Strabag (06/04/2021)

21st Austria weekly - Valneva S&T Strabag 06/04/2021 [pic1]Valneva: an Austrian/French specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need today announced positive data Part A Phase 1/2 clinical trial its inactivated adjuvanted COVID-19 candidate VLA2001. Based this data Company plans to commence a 3 by end April 2021 subject regulatory approval. In study VLA2001-201 three dose...
Hannes Niederhauser Jahre Erfahrung Das Finanzinstitut Facility Services Gmb Axino Solutions Gmb 1st Group

KGO ABC World News Tonight With David Muir April 9, 2021 00:42:00

A baltimore plant that potentially ruined millions of doses that had not yet been sent out. >> 15 million doses would have been distributed over some time to the states and those are lost. >> reporter: but federal officials insisting distribution was always uneven and they still expect j&j to meet its goal of 100 million doses by the end of may. this as doctors warn of a new phase in the pandemic, impacting the young and unvaccinated. >> young kids, particularly those eighth grade and younger, r...
15 Million Eighth Grade The End 100 Million Trouble Breathing Haven T

Counties prepare for Phase 3 of Missouri's vaccination plan

COLUMBIA - Missouri will start Phase 3 of the COVID-19 vaccination plan this Friday. Phase 3 includes all adult Missouri residents, approximately 1.1 million Missourians.  Columbia/Boone County Department of Public Health and Human Services spokesperson Sara Humm said the department is looking forward to the process of getting vaccinated to be easier overall.   "One of the things that will be really helpful is that, you know, we wont have to look at the lists of the tiers and phases to...
Boone County United States Cole County Capital Mall Chezney Schulte Sara Humm
Source: komu.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science